SAB Biotherapeutics Market Cap

SAB Biotherapeutics has a market cap or net worth of $36.99 million as of April 25, 2024. Its market cap has decreased by -24.35% in one year.

Market Cap

36.99M

Enterprise Value

-13.66M

1-Year Change

-24.35%

Ranking

#4742

Market Cap Chart

Since January 12, 2021, SAB Biotherapeutics's market cap has decreased from $134.00M to $36.99M, a decrease of -72.39%. That is a compound annual growth rate of -32.42%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	21.00M	-8.70%
Apr 24, 2024	23.00M	0.88%
Apr 23, 2024	22.80M	-0.87%
Apr 22, 2024	23.00M	2.68%
Apr 19, 2024	22.40M	-3.86%
Apr 18, 2024	23.30M	-3.32%
Apr 17, 2024	24.10M	-5.49%
Apr 16, 2024	25.50M	5.81%
Apr 15, 2024	24.10M	-1.63%
Apr 12, 2024	24.50M	4.26%
Apr 11, 2024	23.50M	-1.26%
Apr 10, 2024	23.80M	2.15%
Apr 9, 2024	23.30M	-
Apr 8, 2024	23.30M	2.64%
Apr 5, 2024	22.70M	-1.73%
Apr 4, 2024	23.10M	-0.86%
Apr 3, 2024	23.30M	-0.85%
Apr 2, 2024	23.50M	4.91%
Apr 1, 2024	22.40M	-5.88%
Mar 28, 2024	23.80M	7.69%
Mar 27, 2024	22.10M	1.38%
Mar 26, 2024	21.80M	-1.80%
Mar 25, 2024	22.20M	-12.94%
Mar 22, 2024	25.50M	4.08%
Mar 21, 2024	24.50M	-2.39%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Bolt Biotherapeutics	42.32M
Cytosorbents	42.29M
ReWalk Robotics	41.55M
Milestone Scientific	41.37M
Xilio Therapeutics	40.60M
iCAD, Inc.	40.34M
Unicycive Therapeutics	39.97M
Cara Therapeutics	39.92M

Market Cap Rankings